Brand Intelligence Graphcompany
Company Overview
About AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Business Model & Competitive Advantage
The company has successfully navigated the Humira patent cliff that began in 2023, when biosimilar competitors entered the US market after years of exclusivity. AbbVie's strategy to offset Humira erosion centered on Skyrizi (risankizumab, for psoriasis and Crohn's disease) and Rinvoq (upadacitinib, for rheumatoid arthritis and other immune conditions), both of which have grown rapidly to partially offset Humira's revenue decline. Revenue in 2024 was approximately $55 billion.
Competitive Landscape 2025–2026
In 2025, AbbVie completed its $8.7 billion acquisition of Cerevel Therapeutics to bolster its neuroscience pipeline with treatments for schizophrenia and Parkinson's disease. The company also acquired Aliada Therapeutics (Alzheimer's focused) for $1.4 billion. AbbVie's aesthetics franchise (Botox via Allergan acquisition, Juvederm) remains a significant revenue contributor. The company's 2025-2026 strategic priorities include advancing its neuroscience and oncology pipeline, executing the Allergan integration fully, and managing pricing pressures from the Inflation Reduction Act's drug negotiation provisions.
Recent Activity
View all →Key Differentiators
Market Leader
AbbVie is recognized as a market leader in the Healthcare sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
CoverMyMeds
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline t
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare AbbVie with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from AbbVie? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim AbbVie Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention AbbVie vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →